DNA-PKc Inhibition Overcomes Taxane Resistance by Promoting Taxane-Induced DNA Damage in Prostate Cancer Cells

Scientists proposed that alterations in DNA damage response pathway contributed to taxane resistance, and identification of these alterations may provide a potential therapeutic target to resensitize docetaxel-refractory mCRPC to taxane-based therapy.